IP Library Patent Application 14973034
Patent Application
App. No. 14/973,034

COMPOSITIONS AND METHODS FOR REDUCING INFECTION IN POULTRY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/973,034
Abstract

Methods and compositions are hereby disclosed for reducing coccidiosis in birds, such as chickens or turkeys, among others. The methods include administering to the bird a lactic acid producing bacterium (LAB) alone or in combination with a vaccine against coccidiosis.

Claims (30)

1 . A composition for reducing pathogen infection in a bird, said composition comprising an effective amount of a lactic acid producing bacterium , said effective amount being an amount of said lactic acid producing bacterium that is capable of reducing coccidiosis in said bird.

2 . The composition of claim 1 , wherein said composition is in a form that can be sprayed.

3 . The composition of claim 1 , wherein said effective amount is an amount of the lactic acid producing bacterium that reduces lesion in the gut of said bird by at least 30% when administered to said bird.

4 . The composition of claim 1 , wherein said effective amount is an amount of the lactic acid producing bacterium that reduces E. coli in the gut of said bird by at least 10-fold when administered to said bird.

5 . The composition of claim 1 , wherein said effective amount is an amount of the lactic acid producing bacterium that reduces Salmonella in the gut of said bird by at least 60% when administered to said bird.

6 . The composition of claim 1 , wherein said effective amount is an amount of the lactic acid producing bacterium that reduces mortality rate of a group of birds by at least 50% when administered to said group of birds.

7 . The composition of claim 1 , wherein said lactic acid producing bacterium is a strain selected from the group consisting of LA51, LA45, NP28, and L411 strains.

8 . The composition of claim 1 , further comprising a vaccine against Coccidiosis.

9 . The composition of claim 1 , wherein said effective amount is an amount of the lactic acid producing bacterium that is capable of reducing Coccidiosis without interfering with effectiveness of a vaccine against Coccidiosis.

10 . The composition of claim 1 , wherein said effective amount is an amount of the lactic acid producing bacterium that enhances effectiveness of a vaccine against Coccidiosis by at least 20%.

11 . The composition of claim 1 , wherein said lactic acid producing bacterium is supplemented to said bird at a dosage of between 1×10 3 and 1×10 10 CFU per day for each bird.

12 . A method for reducing pathogen infection in a bird, said method comprising:

(a) supplement to said bird a composition comprising an effective amount of a lactic acid producing bacterium , said effective amount being an amount of said lactic acid producing bacterium that is capable of reducing Coccidiosis in said bird.

13 . The method of claim 12 , wherein said lactic acid producing bacterium is pre-mixed with feed or water for said bird before being supplemented to said bird.

14 . The method of claim 12 , wherein said lactic acid producing bacterium is sprayed onto said bird.

15 . The method of claim 12 , wherein said effective amount is an amount of the lactic acid producing bacterium that reduces lesion in the gut of said bird by at least 30% when administered to said bird.

16 . The method of claim 12 , wherein said lactic acid producing bacterium being supplemented to the bird at a dosage range of between 1×10 3 and 1×10 10 CFU of lactic acid producing bacterium per day for each bird.

17 . The method of claim 12 , wherein said composition comprises a lactic acid producing bacterium and a vaccine against coccidiosis.

18 . The method of claim 12 , further comprising

(b) administering to said bird a vaccine against coccidiosis,

wherein said step (a) and step (b) are carried out at the same time or sequentially.

19 . The method of claim 12 , wherein said pathogen is selected from the group consisting of Eimeria, Escherichia coli, Salmonella enterica, Staphylococcus aureus, Listeria monocytogenes, Clostridium perfringens , and Campylobacter jejuni.

20 . The method of claim 12 , wherein said bird is from the taxonomic order Anseriformes, Galliformes, or Columbiformes.

21 . The method of claim 12 , wherein said bird is selected from the group consisting of a chicken, a quail, a grouse, a duck, a goose, a swan, a turkey, a pigeon, a partridge, a pheasant, and a fowl.

22 . The method of claim 12 , wherein said composition does not contain significant amount of lactic acid utilizing bacterium.

23 . The method of claim 12 , further comprising a step (c) of predicting the likelihood of developing coccidiosis in said bird, said step (c) preceding said step (a).

24 . The method of claim 12 , further comprising a step (d) of measuring at least one parameter of said bird to assess the effect of the supplement, said step (a) preceding said step (d), said at least one parameter being selected from the group consisting of body weight gain, feed conversion, lesion, pathogen reduction and combination thereof.

25 . The method claim 12 , wherein said step (a) is performed at least daily starting at Day 0 after hatching until at least about 15 days after hatching.

26 . The method of claim 12 , wherein said bird is raised on built-up litter.

27 . The method of claim 12 , wherein the lactic acid producing bacterium is a strain selected from the group consisting of LA51, LA45, NP28, and L411 strains.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2016
From: NUTRITION PHYSIOLOGY COMPANY, LLC
To: CHR. HANSEN A/S
Reel/Frame 038287/0072 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2016
From: LERNER, STEVEN P.
To: NUTRITION PHYSIOLOGY COMPANY, LLC
Reel/Frame 037755/0398 →